The surge came after the United States Food and Drug Administration (US FDA) on April 20, approved the launch of Lupin’s Mirabegron extended-release (ER) tablets, 25 mg, in the United States
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
